ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

by Palomba, Grazia, Atzori, Francesco, Budroni, Mario, Ombra, MariaNeve, Cossu, Antonio, Sini, MariaCristina, Pusceddu, Valeria, Massidda, Bruno, Frau, Barbara, Notari, Francesca, Ionta, MariaTeresa, Palmieri, Giuseppe
Published 2014

Molecular alterations in key-regulator genes among patients with T4 breast carcinoma

by Massidda, Bruno, Sini, MariaCristina, Budroni, Mario, Atzori, Francesco, Deidda, MariaCristina, Pusceddu, Valeria, Perra, MariaTeresa, Sirigu, Paola, Cossu, Antonio, Palomba, Grazia, Ionta, MariaTeresa, Palmieri, Giuseppe
Published 2010

Long-term maintenance of prognostic value of survivin and its relationship with p53 in T4 breast cancer patients

by IONTA, MARIA TERESA, PERRA, MARIA TERESA, ATZORI, FRANCESCO, MAXIA, CRISTINA, PUSCEDDU, VALERIA, DEMURTAS, PAOLO, DEIDDA, MARIA CRISTINA, PIRAS, FRANCA, FRAU, BARBARA, MURTAS, DANIELA, MINERBA, LUIGI, MASSIDDA, BRUNO, SIRIGU, PAOLA
Published 2010

Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia

by Palomba, Grazia, Colombino, Maria, Contu, Antonio, Massidda, Bruno, Baldino, Giovanni, Pazzola, Antonio, Ionta, MariaTeresa, Capelli, Francesca, Trova, Vittorio, Sedda, Tito, Sanna, Giovanni, Tanda, Francesco, Budroni, Mario, Palmieri, Giuseppe, Cossu, Antonio
Published 2012

Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer

by Formica, Vincenzo, Ionta, Maria Teresa, Massidda, Bruno, Vessia, Giacomo, Maiorino, Luigi, Casaretti, Rossana, Natale, Donato, Barberis, Giuseppe, Filippelli, Gianfranco, Greco, Ettore, Blasi, Livio, Mancarella, Sergio, Russo, Anna, Barbato, Enrico, Lullo, Liberato Di, Roselli, Mario
Published in Oncotarget (2017)

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

by Daponte, Antonio, Signoriello, Simona, Maiorino, Luigi, Massidda, Bruno, Simeone, Ester, Grimaldi, Antonio Maria, Caracò, Corrado, Palmieri, Giuseppe, Cossu, Antonio, Botti, Gerardo, Petrillo, Antonella, Lastoria, Secondo, Cavalcanti, Ernesta, Aprea, Pasquale, Mozzillo, Nicola, Gallo, Ciro, Comella, Giuseppe, Ascierto, Paolo Antonio
Published 2013

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian canc...

by Pignata, Sandro, De Placido, Sabino, Biamonte, Rosalbino, Scambia, Giovanni, Di Vagno, Giovanni, Colucci, Giuseppe, Febbraro, Antonio, Marinaccio, Marco, Vernaglia Lombardi, Alessandra, Manzione, Luigi, Cartenì, Giacomo, Nardi, Mario, Danese, Saverio, Valerio, Maria Rosaria, de Matteis, Andrea, Massidda, Bruno, Gasparini, Giampietro, Di Maio, Massimo, Pisano, Carmela, Perrone, Francesco
Published 2006

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

by Ruzzo, Annamaria, Graziano, Francesco, Galli, Francesca, Galli, Fabio, Rulli, Eliana, Lonardi, Sara, Ronzoni, Monica, Massidda, Bruno, Zagonel, Vittorina, Pella, Nicoletta, Mucciarini, Claudia, Labianca, Roberto, Ionta, Maria Teresa, Bagaloni, Irene, Veltri, Enzo, Sozzi, Pietro, Barni, Sandro, Ricci, Vincenzo, Foltran, Luisa, Nicolini, Mario, Biondi, Edoardo, Bramati, Annalisa, Turci, Daniele, Lazzarelli, Silvia, Verusio, Claudio, Bergamo, Francesca, Sobrero, Alberto, Frontini, Luciano, Magnani, Mauro
Published in Sci Rep (2019)

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

by Ruzzo, Annamaria, Graziano, Francesco, Galli, Francesca, Galli, Fabio, Rulli, Eliana, Lonardi, Sara, Ronzoni, Monica, Massidda, Bruno, Zagonel, Vittorina, Pella, Nicoletta, Mucciarini, Claudia, Labianca, Roberto, Ionta, Maria Teresa, Bagaloni, Irene, Veltri, Enzo, Sozzi, Pietro, Barni, Sandro, Ricci, Vincenzo, Foltran, Luisa, Nicolini, Mario, Biondi, Edoardo, Bramati, Annalisa, Turci, Daniele, Lazzarelli, Silvia, Verusio, Claudio, Bergamo, Francesca, Sobrero, Alberto, Frontini, Luciano, Magnani, Mauro
Published in Sci Rep (2020)

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

by Ruzzo, Annamaria, Graziano, Francesco, Galli, Fabio, Giacomini, Elisa, Floriani, Irene, Galli, Francesca, Rulli, Eliana, Lonardi, Sara, Ronzoni, Monica, Massidda, Bruno, Zagonel, Vittorina, Pella, Nicoletta, Mucciarini, Claudia, Labianca, Roberto, Ionta, Maria Teresa, Veltri, Enzo, Sozzi, Pietro, Barni, Sandro, Ricci, Vincenzo, Foltran, Luisa, Nicolini, Mario, Biondi, Edoardo, Bramati, Annalisa, Turci, Daniele, Lazzarelli, Silvia, Verusio, Claudio, Bergamo, Francesca, Sobrero, Alberto, Frontini, Luciano, Magnani, Mauro
Published in Sci Rep (2014)